Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy SELLAS Life Sciences Group stock
Learn how to easily invest in SELLAS Life Sciences Group stock.
SELLAS Life Sciences Group Inc is a biotechnology business based in the US. SELLAS Life Sciences Group shares (SLS) are listed on the NASDAQ and all prices are listed in US Dollars. SELLAS Life Sciences Group employs 7 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in SELLAS Life Sciences Group
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – SLS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
SELLAS Life Sciences Group stock price (NASDAQ: SLS)Use our graph to track the performance of SLS stocks over time.
SELLAS Life Sciences Group shares at a glance
|Latest market close||$4.73|
|52-week range||$4.25 - $15.08|
|50-day moving average||$6.23|
|200-day moving average||$8.62|
|Wall St. target price||$17.83|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.26|
Buy SELLAS Life Sciences Group shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy SELLAS Life Sciences Group stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
SELLAS Life Sciences Group price performance over time
|1 week (2022-01-17)||N/A|
|1 month (2021-12-24)||N/A|
|3 months (2021-10-28)||-45.51%|
|6 months (2021-07-28)||-46.31%|
|1 year (2021-01-28)||-14.00%|
|2 years (2020-01-28)||63.67%|
|3 years (2019-01-28)||219.59%|
|5 years (2017-01-27)||171.84%|
SELLAS Life Sciences Group financials
|Revenue TTM||$9.5 million|
|Gross profit TTM||$1.9 million|
|Return on assets TTM||-39.48%|
|Return on equity TTM||-103.12%|
|Market capitalisation||$80.5 million|
TTM: trailing 12 months
SELLAS Life Sciences Group share dividends
We're not expecting SELLAS Life Sciences Group to pay a dividend over the next 12 months.
Have SELLAS Life Sciences Group's shares ever split?
SELLAS Life Sciences Group's shares were split on a 1:50 basis on 7 November 2019. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your SELLAS Life Sciences Group shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for SELLAS Life Sciences Group shares which in turn could have impacted SELLAS Life Sciences Group's share price.
SELLAS Life Sciences Group share price volatility
Over the last 12 months, SELLAS Life Sciences Group's shares have ranged in value from as little as $4.25 up to $15.08. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while SELLAS Life Sciences Group's is 1.6132. This would suggest that SELLAS Life Sciences Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
SELLAS Life Sciences Group overview
SELLAS Life Sciences Group, Inc. , a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a wilms tumor 1 targeting peptide-based cancer immunotherapeutic agent, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. It also develops nelipepimut-S, a cancer immunotherapy that is in Phase 2b clinical trials for the treatment of early stage breast cancer. The company has strategic collaboration with Merck & Co. , Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors.
SELLAS Life Sciences Group in the news
Sellas Life Sciences Shares Jump As China Approves Galinpepimut IND For Blood Cancer - Benzinga
Earnings playbook: A complete guide to this week's reports, including the first of tech
Markets are expected to remain on edge as the Fed meets in the week ahead
Frequently asked questionsWhat percentage of SELLAS Life Sciences Group is owned by insiders or institutions?
Currently 0.042% of SELLAS Life Sciences Group shares are held by insiders and 15.801% by institutions. How many people work for SELLAS Life Sciences Group?
Latest data suggests 7 work at SELLAS Life Sciences Group. When does the fiscal year end for SELLAS Life Sciences Group?
SELLAS Life Sciences Group's fiscal year ends in December. Where is SELLAS Life Sciences Group based?
SELLAS Life Sciences Group's address is: Times Square Tower, New York, NY, United States, 10036 What is SELLAS Life Sciences Group's ISIN number?
SELLAS Life Sciences Group's international securities identification number is: US81642T2096 What is SELLAS Life Sciences Group's CUSIP number?
SELLAS Life Sciences Group's Committee on Uniform Securities Identification Procedures number is: 363256108
More guides on Finder
Cathie Wood’s ARK analysts predict Bitcoin at $1 million each by 2030
Five major factors contribute to the continued bull run of Bitcoin, ARK says, including growing adoption and long-term focus of investors.
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.
Stocks are dropping; 3 rules for buying on the dip
Downturns often let you buy fundamentally strong stocks at bargain prices, but mind the fundamentals and consider these 3 rules.
The crypto market has lost $1.5 trillion in value — time to buy?
The crypto market wiped out $1.5 trillion in value in just three months.
Bitcoin tumbles past $40,000, altcoins follow
Bitcoin breached the $40,000 price level and may plummet lower as Russia signals a potential ban.
Cardano’s Pavia plot sale shows land rush is on in the metaverse
Cardano’s first metaverse project is available to investors now — if you can find a piece of digital land on sale. Plots sold fast despite the project’s early stage limitations.
Walmart dives deep into the metaverse with crypto and NFTs
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Dogecoin jumps 10% on word you can use it to buy Tesla merch
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
Ask an Expert